Lizak Carol R. 4
4 · Jaguar Health, Inc. · Filed Mar 30, 2022
Insider Transaction Report
Form 4
Lizak Carol R.
Chief Financial Officer
Transactions
- Purchase
Common Stock
2021-09-13$2.51/sh+7,968$20,000→ 7,968 total(indirect: See Footnote) - Award
Restricted stock units
2022-03-28+97,025→ 97,025 total→ Common Stock (97,025 underlying)
Footnotes (5)
- [F1]Securities held directly by the Peter & Carol Lizak Revocable Trust. Ms. Lizak, by virtue of her position as a co-trustee and beneficiary of such trust and her sharing of voting and investment control over the securities held by the trust with her spouse, may be deemed to beneficially own the securities held by the Peter & Carol Lizak Trust for purposes of Section 16.
- [F2]Granted pursuant to the issuer's 2014 Stock Incentive Plan.
- [F3]Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
- [F4]The restricted stock unit grants were approved by the issuer's board of directors on March 28, 2022.
- [F5]The restricted stock units vest in three equal annual installments beginning on May 17, 2023. Vested shares will be delivered to the reporting person on the vesting date provided in the grant notice.